HOME >> MEDICINE >> NEWS
Moderately high homocysteine tied to stroke, Alzheimers risk

DALLAS, Oct. 4 Moderate elevations of homocysteine are associated with a more than five-fold increase in the risk for stroke and almost triple the risk for Alzheimer's disease, according to research in the October issue of Stroke: Journal of the American Heart Association.

Homocysteine is an amino acid believed to be toxic to blood vessels. Several studies have linked high blood levels of it to increased heart attack risk. This study found that homocysteine levels in patients with stroke, Alzheimer's disease or vascular dementia were consistently higher than homocysteine levels in age-matched healthy volunteers.

"Since B vitamins and foods fortified with folate can reduce homocysteine levels, this study suggests that B vitamin supplementation may be appropriate for most adults. It warrants a large placebo-controlled study of folate, and vitamins B6 and B12 in people at risk from dementia and stroke," says lead author Stephen P. McIlroy, Ph.D., a lecturer in geriatric medicine at Queen's University in Belfast, Ireland.

McIlroy and his colleagues studied 83 Alzheimer's patients (average age 77); 78 patients with dementia caused by poor blood flow to the brain, a condition called vascular dementia (average age 77); 64 stroke patients (average age 74) and 71 healthy volunteers (average age 74).

There is some disagreement among scientists about what constitutes an elevated homocysteine level. Here, researchers designated the upper quartile of homocysteine levels of the healthy volunteers 13.3 micromoles per liter (mol/L) or higher as an elevated level.

They also collected data on education, diet, blood pressure, cholesterol, and smoking history. Several of these factors are associated with the risk for Alzheimer's disease, and smoking directly affects homocysteine levels, he says. The researchers also used DNA testing to determine if any of the subjects had a variation in the gene methylenetetrahydrofolate (MTHFR), which can adver
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
3-Oct-2002


Page: 1 2

Related medicine news :

1. New insight into link between homocysteine and stroke
2. Black women with high blood pressure during pregnancy have higher homocysteine levels
3. Coffee drinking elevates plasma homocysteine and risk factors for coronary heart disease
4. High homocysteine levels may double risk of dementia, Alzheimers disease
5. Fifteen football players died during 2002 season, none from heatstroke, study finds
6. Hibernating squirrels provide clues for stroke, Parkinsons
7. New strategy may protect brain against stroke, Parkinsons and Alzheimers
8. Blood pressure drug shown to cut stroke, death risks in common form of hypertension
9. COOL AID safe after stroke, may deter side effect of clot-busters
10. Chiropractic neurologists managing patients autism, stroke, other disorders, according to Journal of the American Chiropractic Association (JACA)
11. Researchers identify novel method of distinguishing Alzheimers disease from other types of dementia

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Moderately high homocysteine tied stroke Alzheimers risk

(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... a top review from Clinicians Report of Provo, Utah. The Clinicians Report is ... a selected group of dentists located throughout the U.S. Whiter Image's In-Office whitening ...
(Date:9/3/2015)... ... 2015 , ... James Earl Jones will be hosting an upcoming VOICES IN ... Jones will introduce a segment that discusses why it is important for the workplace ... be fostered in any working environment. , Employers are out billions of dollars year ...
(Date:9/2/2015)... ... 03, 2015 , ... The Aspen Clinic (TAC), located in Basalt, ... kick-starting and inspiring wellness in the Roaring Fork Valley and beyond. , Amanda Wagner, ... mind-body approach to fitness - we are much more than a gym. Our ...
(Date:9/2/2015)... CA (PRWEB) , ... September 02, 2015 , ... The ... genome by using a complex of the Cas9 nuclease with either a chimeric single ... RNA (tracrRNA)). The ability of any given guide RNA (sgRNA or crRNA) to create ...
(Date:9/2/2015)... , ... September 02, 2015 , ... Based in Beverly ... fleet of truly superb luxury vehicles based on which of the latest and greatest ... the latest step forward in pursuit of this goal: a 2015 Rolls Royce ...
Breaking Medicine News(10 mins):Health News:Whiter Image Products Get Positive Rating From The Clinicians Report 2Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:TAC Introduces New Retreats for Fall Fitness 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 4Health News:Luxury Line Auto Rental Announces Addition of the Rolls Royce Wraith to their Luxury Fleet 2
(Date:9/2/2015)... , Sept. 2, 2015 Research and ... of the "Medical Device Studies: Clinical Evidence ... to their offering. This course ... involved in gathering clinical evidence required for medical ... required for all medical devices and the emphasis ...
(Date:9/2/2015)... Sept. 2, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... Chief Financial Officer of Neurocrine Biosciences, will be presenting ... New York City . The live ... ET (8:25am PT).  The presentation will be webcast and ... http://www.neurocrine.com .   Listeners are encouraged to ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/r6wspz/drug_delivery_in ) has ... "Drug Delivery in Central Nervous System Diseases ... offering. Advances in understanding of ... new avenues and possibilities for improved drug delivery ... enzymes, and receptors that control the penetration of ...
Breaking Medicine Technology:Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 3
Cached News: